Viewing Study NCT01154920

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:09 AM
Ignite Modification Date: 2026-05-15 @ 11:39 AM
Study NCT ID: NCT01154920
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-17
First Post: 2010-06-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Head and Neck Cancer View
None HNSCC View
None Paclitaxel View
None Carboplatin View
None Cetuximab View
None Docetaxel View
None Taxotere View
None Cisplatin View
None Platinol-AQ View
None Platinol View
None CDDP View
None Fluorouracil View
None 5-FU View
None Adrucil View
None Efudex View
None chemotherapy View
None radiation View
None Chemoradiotherapy View